| Mechanisms of resistance to CDK4/6 inhibitors: potential implications and biomarkers for clinical practice A McCartney, I Migliaccio, M Bonechi, C Biagioni, D Romagnoli, ... Frontiers in oncology 9, 666, 2019 | 138 | 2019 |
| Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in AURORA, the Breast International Group (BIG) molecular screening initiative P Aftimos, M Oliveira, A Irrthum, D Fumagalli, C Sotiriou, EN Gal-Yam, ... Cancer discovery 11 (11), 2796-2811, 2021 | 90 | 2021 |
| Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer C Guarducci, M Bonechi, M Benelli, C Biagioni, G Boccalini, D Romagnoli, ... NPJ breast cancer 4 (1), 38, 2018 | 85 | 2018 |
| LEADeR role of miR-205 host gene as long noncoding RNA in prostate basal cell differentiation V Profumo, B Forte, S Percio, F Rotundo, V Doldi, E Ferrari, N Fenderico, ... Nature communications 10 (1), 307, 2019 | 47 | 2019 |
| Tumor purity quantification by clonal DNA methylation signatures M Benelli, D Romagnoli, F Demichelis Bioinformatics 34 (10), 1642-1649, 2018 | 45 | 2018 |
| Plasma thymidine kinase activity as a biomarker in patients with luminal metastatic breast cancer treated with palbociclib within the TREnd trial A McCartney, M Bonechi, F De Luca, C Biagioni, G Curigliano, E Moretti, ... Clinical cancer research 26 (9), 2131-2139, 2020 | 43 | 2020 |
| Cell-free DNA-methylation-based methods and applications in oncology F Galardi, F De Luca, D Romagnoli, C Biagioni, E Moretti, L Biganzoli, ... Biomolecules 10 (12), 1677, 2020 | 41 | 2020 |
| Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor–positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of … A McCartney, C Biagioni, G Schiavon, M Bergqvist, K Mattsson, ... European Journal of Cancer 114, 55-66, 2019 | 35 | 2019 |
| ddSeeker: a tool for processing Bio-Rad ddSEQ single cell RNA-seq data D Romagnoli, G Boccalini, M Bonechi, C Biagioni, P Fassan, R Bertorelli, ... BMC genomics 19, 1-7, 2018 | 27 | 2018 |
| Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial F Galardi, F De Luca, C Biagioni, I Migliaccio, G Curigliano, AM Minisini, ... Breast Cancer Research 23, 1-12, 2021 | 19 | 2021 |
| Biomarker-guided implementation of the old drug temozolomide as a novel treatment option for patients with metastatic colorectal cancer F Pietrantonio, G Randon, D Romagnoli, S Di Donato, M Benelli, ... Cancer Treatment Reviews 82, 101935, 2020 | 18 | 2020 |
| Charting differentially methylated regions in cancer with Rocker-meth M Benelli, GM Franceschini, A Magi, D Romagnoli, C Biagioni, ... Communications Biology 4 (1), 1249, 2021 | 14 | 2021 |
| Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer. NPJ Breast Cancer. 2018; 4: 38 C Guarducci, M Bonechi, M Benelli, C Biagioni, G Boccalini, D Romagnoli, ... | 10 | |
| Mechanisms of resistance to CDK4/6 inhibitors: potential implications and biomarkers for clinical practice. Front Oncol 9: 666 A McCartney, I Migliaccio, M Bonechi, C Biagioni, D Romagnoli, ... | 6 | 2019 |
| An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06) E Risi, C Biagioni, M Benelli, I Migliaccio, A McCartney, M Bonechi, ... Therapeutic advances in medical oncology 11, 1758835919891608, 2019 | 4 | 2019 |
| Clinico-molecular characteristics associated with outcomes in breast cancer patients treated with CDK4/6 inhibitors: Results from the AURORA Molecular Screening Initiative. E Agostinetto, C Sotiriou, M Ignatiadis, T Antoniolli Crestani, D Venet, ... Journal of Clinical Oncology 41 (16_suppl), 1019-1019, 2023 | 3 | 2023 |
| Exploring serum NMR-based metabolomic fingerprint of colorectal cancer patients: Effects of surgery and possible associations with cancer relapse A Vignoli, E Mori, S Di Donato, L Malorni, C Biagioni, M Benelli, ... Applied Sciences 11 (23), 11120, 2021 | 3 | 2021 |
| Abstract P6-09-02: Effects of palbociclib on thymidine kinase-1 (TK1) in hormone receptor positive (HR+) breast cancer cell lines M Bonechi, I Migliaccio, M Benelli, D Romagnoli, M Bergqvist, K Mattsson, ... Cancer Research 79 (4_Supplement), P6-09-02-P6-09-02, 2019 | 3 | 2019 |
| BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors A Petrelli, S Rizzolio, F Pietrantonio, SE Bellomo, M Benelli, L De Cecco, ... Cancer Research 83 (10), 1699-1710, 2023 | 2 | 2023 |
| MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples D Romagnoli, A Nardone, F Galardi, M Paoli, F De Luca, C Biagioni, ... Briefings in Bioinformatics 24 (2), bbad015, 2023 | 2 | 2023 |
